Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events

Stroke is the leading cause of disability and mortality worldwide. After an acute cerebrovascular ischemia, recurrent vascular events, including recurrent stroke or transient ischemic accidents (TIA), occur in around 20% of cases within the first 3 months. In order to minimize this percentage, antip...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Med
Glavni autori: De Luca, Leonardo, Bellettini, Elisa, Di Maio, Dario, Natale, Enrico, Putini, Rita Lucia, Anticoli, Sabrina, Colivicchi, Furio, Calabrò, Paolo, Musumeci, Francesco, Gabrielli, Domenico
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8072634/
https://ncbi.nlm.nih.gov/pubmed/33923493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10081721
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items